Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
CytoDyn Inc. (CYDY) had Return on Equity of 5.12% for the most recently reported fiscal quarter, ending 2025-02-28.
| Income Statement Financials | |
-- |
|
$-5.12M |
|
-- |
|
-- |
|
$4.00M |
|
$-4.00M |
|
$-0.76M |
|
$-4.76M |
|
$-5.08M |
|
$-4.76M |
|
$-4.76M |
|
$-4.76M |
|
$-5.08M |
|
$-4.00M |
|
$-3.89M |
|
1.23B |
|
1.23B |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$20.98M |
|
-- |
|
$0.21M |
|
$21.19M |
|
$70.56M |
|
-- |
|
$43.60M |
|
$114.17M |
|
$-92.98M |
|
$-92.98M |
|
$-92.98M |
|
1.23B |
|
| Cash Flow Statement Financials | |
$-3.10M |
|
-- |
|
$9.69M |
|
$9.81M |
|
$16.40M |
|
$6.59M |
|
$1.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.30 |
|
-- |
|
-- |
|
-- |
|
-0.29 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
5.12% |
5.12% |
|
-22.45% |
|
5.12% |
|
$-0.08 |
|
$-0.00 |
|
$-0.00 |
|